President's message

"Connection: a dynamic and interactive vision of innovation"

It is with great pleasure that I welcome you to Oncodesign, which is located in the heart of Burgundy among the world’s best vineyards. In the image of our noble vines, we have sunk our roots in the peacefulness of this historic French soil, maturing our identity and becoming the reference in our field just 12 years after our creation.

Our unique platform is centered on the preclinical evaluation of anticancer therapies. Its uniqueness lies in our rich bank of in vivo models and by the performance of our innovative and “qualifying” approach to drug evaluation and development. Indeed, the highest standards in the pursuit of antitumor efficacy give each molecule the best opportunity to succeed without eliminating a potential molecule too quickly. This constitutes a decisive benefit to our clients in optimizing their investment. The main advantage of this innovative approach is to give each "candidate drug" the best opportunity of demonstrating its therapeutic potential, with the very best of them following their course, under optimum conditions, to greatest human benefit.
Innovation is an integral part of our company’s culture; it governs our values, ethics, directs our development and offers you a high degree of added value. Only high level, competitive research can bring about innovation. It is for this reason that Oncodesign reinvests 15% of its annual revenues in the optimization of its technological platform, not allowing our level of inventiveness fall behind the innovative strategies of our clients.

Our investment program (€ 9 million over the last three years with € 2 million invested in our internal R&D) is centered on the strong concept of “Connection”, which is driven and symbolized by the transversal and synergistic connection of our expertise, technology and personnel. The location of a new research center dedicated to the evaluation of anticancer therapies in an environment of higher learning in Dijon (3,000m² complete with an imaging platform and designed for a staff of 60) is the best proof of our commitment to a “Connection” and our finest ambassador.

So, welcome once again to all of our clients and partners with whom we collaborate on a daily basis to drive back cancer and one day defeat this cruel paradox - “the life that destroys life”. For it is in humbly and wholeheartedly dedicating our energy to health and life that we find our motivation.

Philippe Genne, PhD
President and CEO